TED

Search documents
Cricut to Announce Second Quarter 2025 Financial Results on August 5, 2025
Globenewswire· 2025-07-15 20:05
Core Points - Cricut, Inc. will report its financial results for Q2 2025 on August 5, 2025, after U.S. market close [1] - A conference call and webcast will be held on the same day at 3:00 p.m. Mountain Time [1] - The earnings call will be accessible via Cricut's investor relations website [2] Company Overview - Cricut, Inc. is a creative technology company that provides a connected platform for DIY projects, including smart cutting machines and design software [4] - The company offers a range of products, including the Cricut Maker series, Cricut Explore series, Cricut Joy, and Cricut Venture, along with tools like Cricut EasyPress and Infusible Ink [4] - Cricut fosters a community of millions of users globally, enhancing the creative experience [4] Investor Relations - Cricut will use its investor relations website and Cricut News Blog to disclose material non-public information [5] - Stakeholders are encouraged to monitor these platforms along with press releases and SEC filings for updates [5]
Can OXY's Integrated Portfolio Continue to Create Long-Term Value?
ZACKS· 2025-07-15 15:51
Core Insights - Occidental Petroleum Corporation (OXY) is distinguished in the oil and gas sector due to its strategically integrated portfolio, which enhances operational efficiency and supports long-term growth in shareholder value [1] Upstream Operations - Occidental's upstream strength is highlighted by its leadership in the Permian Basin, where it possesses extensive low-cost acreage, leading to consistent production growth and operational efficiencies [2] - The integration of midstream operations allows Occidental to optimize transportation costs and maintain robust margins, even during price downturns [2] Chemical Manufacturing - OxyChem serves as a valuable hedge through the production of essential basic chemicals and PVC, contributing to earnings diversification and stabilizing overall performance amid fluctuating commodity prices [3] Capital Allocation and Financial Health - With a disciplined capital allocation strategy and ongoing debt reduction, Occidental is positioned to deliver sustainable shareholder returns, supported by its balanced portfolio across oil, gas, chemicals, and infrastructure [4] Integrated Business Model Benefits - Oil and gas companies benefit from integrated assets by enhancing cost efficiency, improving supply-chain control, and ensuring stable cash flows across fluctuating commodity cycles [5] Earnings Performance - Occidental has consistently beaten earnings estimates over the past four quarters, with an average surprise of 24.3% [7][9] Stock Valuation - Occidental's shares are currently trading at a premium, with a trailing 12-month EV/EBITDA of 5.27X compared to the industry average of 4.91X [10] - The company's shares have increased by 19.2% over the past three months, outperforming the Zacks Oil and Gas-Integrated-United States industry's growth of 12.4% [12]
Digital asset ETPs surge in Q2 as investors flock to regulated crypto exposure, Fineqia analysis shows
Proactiveinvestors NA· 2025-07-15 15:46
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Mike Waltz faces grilling from Senators in UN confirmation hearing after Signal-gate
MSNBC· 2025-07-15 14:55
So Ryan, Democrats have warned this is going to be a brutal hearing. What do we expect. Well, there's no doubt that Democrats feel as though they have not gotten the answers that they've been looking for as it relates to this controversy over this signal chat that appeared to provide sensitive information about a military operation in which a journalist was inadvertently added to.They have questioned other administration officials about it in a public forum, most specifically the Secretary of Defense Pete H ...
Oceaneering Wins ROV and Services Contract From Esso Angola
ZACKS· 2025-07-15 13:06
Key Takeaways Oceaneering won a 3-year, $80M-$90M contract from Esso Angola for subsea services starting July 1, 2025. The deal includes advanced ROVs, IWOCS, hydrate remediation, inspection and satellite systems. OII's local subsidiaries support workforce development, aligning with Angola's national content goals.Oceaneering International (OII) , a global leader in engineered services and products, has once again demonstrated its unmatched capability in offshore operations by securing a significant contr ...
Sirius, long commercial-free in cars, is betting on advertising to capture new listeners
CNBC· 2025-07-15 13:00
Core Viewpoint - SiriusXM is shifting its business strategy towards an ad-supported subscription model to drive revenue and retain customers in a competitive audio entertainment market [3][12]. Group 1: New Subscription Plan - The company launched its first ad-supported subscription plan, SiriusXM Play, priced at under $7 per month, offering a limited selection of commercials across music, sports, news, and talk shows [2][4]. - This new plan aims to convert free trial users into long-term subscribers, particularly targeting drivers who do not renew after their trial period [6][7]. Group 2: Market Position and Strategy - SiriusXM is focusing on its core in-car radio business, which constitutes 90% of its customer base, while also planning to expand the ad-supported option to nearly 100 million vehicles by the end of 2025 [4][13]. - The company is reallocating resources from high-cost streaming audiences to enhance its in-car offerings and advertising strategy [12][13]. Group 3: Financial Performance - In the most recent quarter, SiriusXM reported $2.07 billion in revenue, a 4% decline year-over-year, with net income falling to $204 million from $241 million [15]. - The company generated approximately $1.8 billion in total ad revenue for 2024, with $394 million reported in the latest quarter, reflecting a decline from the previous year [16]. Group 4: Competitive Landscape - SiriusXM faces increasing competition from streaming services like Spotify and Apple Music, which are gaining traction in the in-car audio space [11]. - The company is drawing parallels to Netflix's previous struggles with subscriber growth and its eventual shift to an ad-supported model [9][10].
Limitless X Holdings Inc. Forms HealthMD Inc. to Drive Innovation, Accelerate Growth and Increase Shareholder Value in Wellness Sector
Globenewswire· 2025-07-15 12:30
LOS ANGELES, CA, July 15, 2025 (GLOBE NEWSWIRE) -- Limitless X Holdings, Inc. (OTCQB: LIMX), a leading force in the Health, Wellness, and Lifestyle sectors, is pleased to announce the registration and corporate filing of its wholly owned subsidiary, HealthMD Inc. This strategic expansion aligns with Limitless X's mission to empower individuals through transformative wellness solutions that help them Look Good. Feel Great. Live Limitless. FOCUSED ON STRATEGIC GROWTH AND SHAREHOLDER VALUE HealthMD Inc. is exp ...
IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan
Globenewswire· 2025-07-15 12:05
Core Points - IMUNON, Inc. has received approval from the Nasdaq Hearing Panel for an exception to complete its compliance plan, allowing the company to maintain its Nasdaq listing [1][2] - The Nasdaq Hearing Panel noted that IMUNON has achieved compliance with the Equity Rule through recent fundraising activities and will implement a compliance plan to meet minimum shareholder equity and bid price requirements [2][3] - The Panel approved a tailored exception for IMUNON to regain compliance within a designated timeframe, rather than the full 180 days initially requested [3] Company Overview - IMUNON is a clinical-stage biotechnology company focused on developing innovative treatments that utilize the body's natural mechanisms to generate effective responses against various diseases [5] - The company is advancing its non-viral DNA technology, with its lead clinical program, IMNN-001, being a DNA-based immunotherapy for advanced ovarian cancer [6] - IMNN-001 has completed multiple clinical trials, including a Phase 2 trial, and the company has also conducted a first-in-human study for its COVID-19 booster vaccine, IMNN-101 [6]
Nexxen Expected to Expand its CTV OEM Relationships and ACR Data Reach in Europe Through Vestel's Strategic Partnership with VIDAA
GlobeNewswire News Room· 2025-07-15 11:30
Core Insights - Nexxen International Ltd. anticipates benefits from the strategic partnership between VIDAA and Vestel, enhancing its position in the advertising technology sector [1][4] - Nexxen holds a 2.439% ownership stake in VIDAA and has signed a non-binding MOU for potential extension and expansion of their partnership [2][4] - The partnership between VIDAA and Vestel is expected to expand VIDAA's CTV operating system reach, particularly in Europe, and increase the scale of its global ACR data [3][4] Company Overview - Nexxen is a global advertising technology platform specializing in data and advanced TV, with a focus on providing flexible solutions for advertisers, agencies, publishers, and broadcasters [7] - The company operates a unified technology stack that includes a demand-side platform (DSP) and supply-side platform (SSP), with a core Nexxen Data Platform [7] - Nexxen is headquartered in Israel and has a global presence with offices in the United States, Canada, Europe, and Asia-Pacific [8] Industry Context - VIDAA is recognized as a leading smart TV platform, with over 400 brand partners and more than 40 million connected devices worldwide [9] - The partnership with Vestel, a major connected TV manufacturer, is expected to enhance VIDAA's market position and expand its operating system's reach [3][4] - The collaboration is seen as a strategic move to leverage advanced TV data in advertising, which is poised for substantial growth, particularly in the European market [6][4]
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases
Globenewswire· 2025-07-15 11:30
Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference Plus will also host an educational symposium with leading experts titled, “Reimagining Your Approach to Leptomeningeal Metastases” HOUSTON, July 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, today announces the oral presentat ...